Clinical responses of large cell neuroendocrine carcinoma of the lung to cisplatin-based chemotherapy

Lung Cancer

Volumn 49, Issue 2, 2005, Pages 217-223

  Yamazaki, Shigeo ^a,b   Sekine, Ikuo ^a   Matsuno, Yoshihiro ^a   Takei, Hidefumi ^a   Yamamoto, Noboru ^a   Kunitoh, Hideo ^a   Ohe, Yuichiro ^a   Tamura, Tomohide ^a   Kodama, Tetsuro ^a   Asamura, Hisao ^a   Tsuchiya, Ryosuke ^a   Saijo, Nagahiro ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b KEIYUKAI SAPPORO HOSPITAL   (Japan)

Author keywords

Chemotherapy; Cisplatin; Lung cancer; Neuroendocrine carcinoma

Indexed keywords

CISPLATIN; ETOPOSIDE; MITOMYCIN; VINDESINE;

ADULT; AGED; ARTICLE; AUTOPSY; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; HUMAN; HUMAN TISSUE; LARGE CELL CARCINOMA; LUNG CARCINOMA; MALE; NEUROENDOCRINE DISEASE; POSTOPERATIVE CARE; PRIORITY JOURNAL;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, LARGE CELL; CARCINOMA, NEUROENDOCRINE; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; CISPLATIN; ETOPOSIDE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MITOMYCIN; NEOPLASM STAGING; TREATMENT OUTCOME; VINDESINE;

EID: 22044450203     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2005.01.008     Document Type: Article

References (22)

1. W.D. Travis, R.I. Linnoila, M.G. Tsokos, C.L. Hitchcock, G.B. Cutler Jr., and L. Nieman Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. An ultrastructural, immunohistochemical, and flow cytometric study of 35 cases Am J Surg Pathol 15 1991 529 553
2. W. Travis, B. Corrin, Y. Shimosato, and E. Brambilla Histological typing of lung and pleural tumours 1999 Springer-Verlag Berlin
3. V.W. Rusch, D.S. Klimstra, and E.S. Venkatraman Molecular markers help characterize neuroendocrine lung tumors Ann Thorac Surg 62 1996 798 809 [discussions 09-10]
4. C.M. Dresler, J.H. Ritter, G.A. Patterson, E. Ross, M.S. Bailey, and M.R. Wick Clinical-pathologic analysis of 40 patients with large cell neuroendocrine carcinoma of the lung Ann Thorac Surg 63 1997 180 185
5. W.D. Travis, W. Rush, D.B. Flieder, R. Falk, M.V. Fleming, and A.A. Gal Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid Am J Surg Pathol 22 1998 934 944
6. H. Takei, H. Asamura, A. Maeshima, K. Suzuki, H. Kondo, and T. Niki Large cell neuroendocrine carcinoma of the lung: a clinicopathologic study of eighty-seven cases J Thorac Cardiovasc Surg 124 2002 285 292
7. S.L. Graziano, R. Mazid, N. Newman, A. Tatum, A. Oler, and J.A. Mortimer The use of neuroendocrine immunoperoxidase markers to predict chemotherapy response in patients with non-small-cell lung cancer J Clin Oncol 7 1989 1398 1406
8. J.T. Schleusener, H.D. Tazelaar, S.H. Jung, S.S. Cha, P.J. Cera, and J.L. Myers Neuroendocrine differentiation is an independent prognostic factor in chemotherapy-treated nonsmall cell lung carcinoma Cancer 77 1996 1284 1291
9. J. Carles, R. Rosell, A. Ariza, I. Pellicer, J.J. Sanchez, and G. Fernandez-Vasalo Neuroendocrine differentiation as a prognostic factor in non-small cell lung cancer Lung Cancer 10 1993 209 219
10. R.J. Ginsberg, E.E. Vokes, and K. Rosenzweig Non-small cell lung cancer V.T. DeVita S. Hellman S.A. Rosenberg Cancer: principles & practice of oncology 6th ed. 2001 Lippincott Williams & Wilkins Philadelphia 925 983
11. J. Murren, E. Glatstein, and H.I. Pass Small cell lung cancer V.T. DeVita S. Hellman S.A. Rosenberg Cancer: principles & practice of oncology 6th ed. 2001 Lippincott Williams & Wilkins Philadelphia 983 1018
12. H. Fushimi, M. Kikui, H. Morino, S. Yamamoto, R. Tateishi, and A. Wada Histologic changes in small cell lung carcinoma after treatment Cancer 77 1996 278 283
13. L.H. Sobin, and C. Wittenkind TNM classification of malignant tumors 1997 Wiley-Liss New York
14. Handbook for reporting results of cancer treatment. Geneva: World Health Organization (WHO); 1979.
15. E.L.M.P. Kaplan Non-parametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
16. S.X. Jiang, T. Kameya, M. Shoji, Y. Dobashi, J. Shinada, and H. Yoshimura Large cell neuroendocrine carcinoma of the lung: a histologic and immunohistochemical study of 22 cases Am J Surg Pathol 22 1998 526 537
17. A. Iyoda, K. Hiroshima, T. Toyozaki, Y. Haga, T. Fujisawa, and H. Ohwada Clinical characterization of pulmonary large cell neuroendocrine carcinoma and large cell carcinoma with neuroendocrine morphology Cancer 91 2001 1992 2000
18. M. Paci, A. Cavazza, V. Annessi, I. Putrino, G. Ferrari, and S. De Franco Large cell neuroendocrine carcinoma of the lung: a 10-year clinicopathologic retrospective study Ann Thorac Surg 77 2004 1163 1167
19. Y.J. Yang, C.T. Steele, X.L. Ou, K.P. Snyder, and L.J. Kohman Diagnosis of high-grade pulmonary neuroendocrine carcinoma by fine-needle aspiration biopsy: nonsmall-cell or small-cell type? Diagn Cytopathol 25 2001 292 300
20. B.A. Wiatrowska, J. Krol, and M.F. Zakowski Large-cell neuroendocrine carcinoma of the lung: proposed criteria for cytologic diagnosis Diagn Cytopathol 24 2001 58 64
21. J. Mazieres, G. Daste, L. Molinier, J. Berjaud, M. Dahan, and M. Delsol Large cell neuroendocrine carcinoma of the lung: pathological study and clinical outcome of 18 resected cases Lung Cancer 37 2002 287 292
22. W.D. Travis, A.A. Gal, T.V. Colby, D.S. Klimstra, R. Falk, and M.N. Koss Reproducibility of neuroendocrine lung tumor classification Hum Pathol 29 1998 272 279